Sanofi-Aventis SA (SNY) said Tuesday that Jiri Michal, the chief executive of Zentiva NV, the Czech-based generics unit of the French-Swiss pharmaceutical company, is stepping down as of July 1 after 36 years at the company.
Sanofi-Aventis SA (SNY) said Tuesday that Jiri Michal, the chief executive of Zentiva NV, the Czech-based generics unit of the French-Swiss pharmaceutical company, is stepping down as of July 1 after 36 years at the company.
most viewed
© 2023 The Prague Monitor
